Fundraising FoxConvexity Scientific
New Haven, US · Founded 2014 · Delaware corporation · 2 known investors
Find your way into Convexity Scientific
Sign up to see every warm intro you have to Convexity Scientific
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Convexity Scientific team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
IA
Ilaa AgarwalExecutive
SB
Stacie BratcherExecutive
PR
paul reifersonExecutive
RF
ralph fingerExecutive
JB
MW
Mike WatersNamed on SEC filing
AA
Andrew AgwunobiNamed on SEC filing
Board
KR
RW
Richard WilmotBoard director
HW
Henry WeinsteinBoard director
SB
Stephen BrusoBoard director
DW
Douglas WennersBoard director
Investors · 2
Connecticut InnovationsreportedNew Haven · $500K – $2M
How we know: funding news · Not right? Tell us
HighCape CapitalreportedWestport
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$49.9M disclosed across 7 rounds · 2016–2026
▶$10MraisedAug 2026 · 7 investors · Other Health CareRule 506(b)
▶$10MraisedAug 2026 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jennifer BarrettaExecutive Officer
- Kevin RakinDirector
- Henry WeinsteinDirector
- Stephen BrusoDirector
- Mike WatersDirector
- Andrew AgwunobiDirector
- Offering amount
- $13M
- Amount sold
- $10M
- First sale
- Jul 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.7MraisedAug 2026 · 5 investors · Other Health CareRule 506(b)
▶$2.7MraisedAug 2026 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jennifer BarrettaExecutive Officer
- Kevin RakinDirector
- Henry WeinsteinDirector
- Stephen BrusoDirector
- Andrew AgwunobiDirector
- Mike WatersDirector
- Offering amount
- $2.9M
- Amount sold
- $2.7M
- Proceeds to insiders
- $285.6K
- First sale
- Feb 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.9MraisedDec 2025 · 6 investors · Other Health CareRule 506(b)
▶$5.9MraisedDec 2025 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Douglas WennersDirector
- Richard WilmotDirector
- Kevin RakinDirector
- Abi SundaramoorthyExecutive Officer
- Ilaa AgarwalExecutive Officer
- Henry WeinsteinDirector
- Jennifer BarrettaExecutive Officer
- Stephen BrusoDirector
- Offering amount
- $6.2M
- Amount sold
- $5.9M
- Proceeds to insiders
- $683K
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.4MraisedJun 2025 · 5 investors · Other Health CareRule 506(b)
▶$2.4MraisedJun 2025 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Richard WilmotDirector
- Kevin RakinDirector
- Henry WeinsteinDirector
- Stephen BrusoDirector
- Ilaa AgarwalExecutive Officer
- Douglas WennersDirector
- Stacie BratcherExecutive Officer
- Offering amount
- $3.5M
- Amount sold
- $2.4M
- First sale
- May 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$25MraisedNov 2021 · 7 investors · Other Health CareRule 506(b)
▶$25MraisedNov 2021 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Geoff MatousExecutive Officer
- Kevin RakinDirector
- Stephen BrusoDirector
- Alex WaldronExecutive Officer, Director
- Ryan McMillianExecutive Officer
- Henry WeinsteinDirector
- Offering amount
- $25M
- Amount sold
- $25M
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.5MraisedOct 2019 · 3 investors · BiotechnologyRule 506(b)
▶$3.5MraisedOct 2019 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kevin CrowleyDirector
- Henry WeinsteinDirector
- Kevin RakinDirector
- Geoff MatousExecutive Officer
- Ralph FingerExecutive Officer, Director
- Offering amount
- $14.9M
- Amount sold
- $3.5M
- Proceeds to insiders
- $190K
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$300KraisedMay 2016 · 12 investors · Other Health CareRule 506(b)
▶$300KraisedMay 2016 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- paul reifersonExecutive Officer, Director
- ralph fingerExecutive Officer, Director
- Offering amount
- $600K
- Amount sold
- $300K
- Minimum investment
- $500
- First sale
- Apr 2016
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Convexity Scientific went on to found or lead other companies.
Frequently asked questions
- Who are Convexity Scientific's investors?
- Convexity Scientific's investors include Connecticut Innovations, HighCape Capital.
- How much funding has Convexity Scientific raised?
- Convexity Scientific has disclosed $49.9M raised across 7 rounds.
- Where is Convexity Scientific headquartered?
- Convexity Scientific is headquartered in New Haven, US.